These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


540 related items for PubMed ID: 27296136

  • 1. A Recombinant Rift Valley Fever Virus Glycoprotein Subunit Vaccine Confers Full Protection against Rift Valley Fever Challenge in Sheep.
    Faburay B, Wilson WC, Gaudreault NN, Davis AS, Shivanna V, Bawa B, Sunwoo SY, Ma W, Drolet BS, Morozov I, McVey DS, Richt JA.
    Sci Rep; 2016 Jun 14; 6():27719. PubMed ID: 27296136
    [Abstract] [Full Text] [Related]

  • 2. A glycoprotein subunit vaccine elicits a strong Rift Valley fever virus neutralizing antibody response in sheep.
    Faburay B, Lebedev M, McVey DS, Wilson W, Morozov I, Young A, Richt JA.
    Vector Borne Zoonotic Dis; 2014 Oct 14; 14(10):746-56. PubMed ID: 25325319
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Evaluation of the Efficacy, Potential for Vector Transmission, and Duration of Immunity of MP-12, an Attenuated Rift Valley Fever Virus Vaccine Candidate, in Sheep.
    Miller MM, Bennett KE, Drolet BS, Lindsay R, Mecham JO, Reeves WK, Weingartl HM, Wilson WC.
    Clin Vaccine Immunol; 2015 Aug 14; 22(8):930-7. PubMed ID: 26041042
    [Abstract] [Full Text] [Related]

  • 5. A single immunization with MVA expressing GnGc glycoproteins promotes epitope-specific CD8+-T cell activation and protects immune-competent mice against a lethal RVFV infection.
    López-Gil E, Lorenzo G, Hevia E, Borrego B, Eiden M, Groschup M, Gilbert SC, Brun A.
    PLoS Negl Trop Dis; 2013 Aug 14; 7(7):e2309. PubMed ID: 23875044
    [Abstract] [Full Text] [Related]

  • 6. Efficacy assessment of an MVA vectored Rift Valley Fever vaccine in lambs.
    Busquets N, Lorenzo G, López-Gil E, Rivas R, Solanes D, Galindo-Cardiel I, Abad FX, Rodríguez F, Bensaid A, Warimwe G, Gilbert SC, Domingo M, Brun A.
    Antiviral Res; 2014 Aug 14; 108():165-72. PubMed ID: 24933081
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Rift Valley fever virus vaccine lacking the NSs and NSm genes is safe, nonteratogenic, and confers protection from viremia, pyrexia, and abortion following challenge in adult and pregnant sheep.
    Bird BH, Maartens LH, Campbell S, Erasmus BJ, Erickson BR, Dodd KA, Spiropoulou CF, Cannon D, Drew CP, Knust B, McElroy AK, Khristova ML, Albariño CG, Nichol ST.
    J Virol; 2011 Dec 14; 85(24):12901-9. PubMed ID: 21976656
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Four-segmented Rift Valley fever virus-based vaccines can be applied safely in ewes during pregnancy.
    Wichgers Schreur PJ, van Keulen L, Kant J, Kortekaas J.
    Vaccine; 2017 May 25; 35(23):3123-3128. PubMed ID: 28457675
    [Abstract] [Full Text] [Related]

  • 15. Rift Valley fever virus subunit vaccines confer complete protection against a lethal virus challenge.
    de Boer SM, Kortekaas J, Antonis AF, Kant J, van Oploo JL, Rottier PJ, Moormann RJ, Bosch BJ.
    Vaccine; 2010 Mar 08; 28(11):2330-9. PubMed ID: 20056185
    [Abstract] [Full Text] [Related]

  • 16. Safety and immunogenicity of a live attenuated Rift Valley Fever recombinant arMP-12ΔNSm21/384 vaccine candidate for sheep, goats and calves.
    Boumart Z, Daouam S, Bamouh Z, Jazouli M, Tadlaoui KO, Dungu B, Bettinger G, Watts DM, Elharrak M.
    Vaccine; 2019 Mar 14; 37(12):1642-1650. PubMed ID: 30773401
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Protection of sheep against Rift Valley fever virus and sheep poxvirus with a recombinant capripoxvirus vaccine.
    Soi RK, Rurangirwa FR, McGuire TC, Rwambo PM, DeMartini JC, Crawford TB.
    Clin Vaccine Immunol; 2010 Dec 14; 17(12):1842-9. PubMed ID: 20876822
    [Abstract] [Full Text] [Related]

  • 19. Expression of Rift Valley fever virus N-protein in Nicotiana benthamiana for use as a diagnostic antigen.
    Mbewana S, Meyers AE, Weber B, Mareledwane V, Ferreira ML, Majiwa PAO, Rybicki EP.
    BMC Biotechnol; 2018 Dec 11; 18(1):77. PubMed ID: 30537953
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 27.